Prolonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex

Neuropharmacology

Volumn 62, Issue 4, 2012, Pages 1808-1822

  Wang, Huai Xing ^a   Gao, Wen Jun ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

AMPA receptors; Fast spiking interneurons; MK 801; NMDA receptor hypofunction; Schizophrenia

Indexed keywords

AMPA RECEPTOR; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CALCIUM; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AFTERHYPERPOLARIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CELL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; INTERNEURON; MEMBRANE STEADY POTENTIAL; NERVE ENDING; NERVE FIBER TRANSPORT; NERVE POTENTIAL; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SCHIZOPHRENIA;

ACTION POTENTIALS; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; INTERNEURONS; MINIATURE POSTSYNAPTIC POTENTIALS; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 84856443222     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.11.024     Document Type: Article

References (112)

1. Z. Abdul-Monim, G.P. Reynolds, and J.C. Neill The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm Behav. Brain Res. 169 2006 263 273
2. T. Abekawa, K. Ito, S. Nakagawa, and T. Koyama Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats Psychopharmacology (Berl) 192 2007 303 316 (Pubitemid 46701582)
3. H. Adesnik, and R.A. Nicoll Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation J. Neurosci. 27 2007 4598 4602 (Pubitemid 46663561)
4. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, W.P. Hetrick, S.G. Potkin, C.A. Sandman, W.E. Bunney Jr., and E.G. Jones Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J. Neurosci. 16 1996 19 30 (Pubitemid 26010694)
5. N. Amitai, and A. Markou Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment Pharmacol. Biochem. Behav. 93 2009 248 257
6. N. Amitai, S. Semenova, and A. Markou Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats Psychopharmacology (Berl) 193 2007 521 537 (Pubitemid 47094377)
7. D.M. Ashby, D. Habib, H.C. Dringenberg, J.N. Reynolds, and R.J. Beninger Subchronic MK-801 treatment and post-weaning social isolation in rats: differential effects on locomotor activity and hippocampal long-term potentiation Behav. Brain Res. 212 2010 64 70
8. A. Bacci, J.R. Huguenard, and D.A. Prince Modulation of neocortical interneurons: extrinsic influences and exercises in self-control Trends Neurosci. 28 2005 602 610 (Pubitemid 41476691)
9. A. Barbon, F. Fumagalli, L. La Via, L. Caracciolo, G. Racagni, M. Andrea Riva, and S. Barlati Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex Exp. Neurol. 208 2007 54 62 (Pubitemid 47600147)
10. J.E. Belforte, V. Zsiros, E.R. Sklar, Z. Jiang, G. Yu, Y. Li, E.M. Quinlan, and K. Nakazawa Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes Nat. Neurosci. 13 2010 76 83
11. F.M. Benes Emerging principles of altered neural circuitry in schizophrenia Brain Res. Brain Res. Rev. 31 2000 251 269 (Pubitemid 30136180)
12. N. Berretta, and R.S. Jones Tonic facilitation of glutamate release by presynaptic N-methyl-d-aspartate autoreceptors in the entorhinal cortex Neuroscience 75 1996 339 344 (Pubitemid 26361326)
13. C.l. Bidoret, A. Ayon, B. Barbour, and M. Casado Presynaptic NR2A-containing NMDA receptors implement a high-pass filter synaptic plasticity rule Proc. Natl. Acad. Sci. U S A 106 2009 14126 14131
14. D.J. Brasier, and D.E. Feldman Synapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortex J. Neurosci. 28 2008 2199 2211 (Pubitemid 351317616)
15. I. Braun, J. Genius, H. Grunze, A. Bender, H.J. Moller, and D. Rujescu Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism Schizophr. Res. 97 2007 254 263 (Pubitemid 350088379)
16. W.T. Carpenter, and J.I. Koenig The evolution of drug development in schizophrenia: past issues and future opportunities Neuropsychopharmacology 33 2008 2061 2079 (Pubitemid 351992095)
17. R.L. Clem, and A. Barth Pathway-specific trafficking of native AMPARs by in vivo experience Neuron 49 2006 663 670 (Pubitemid 43290126)
18. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
19. L.G. Coleman Jr., L.F. Jarskog, S.S. Moy, and F.T. Crews Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatment Pharmacol. Biochem. Behav. 93 2009 322 330
20. R. Corlew, Y. Wang, H. Ghermazien, A. Erisir, and B.D. Philpot Developmental switch in the contribution of presynaptic and postsynaptic NMDA receptors to long-term depression J. Neurosci. 27 2007 9835 9845 (Pubitemid 47403998)
21. R. Corlew, D.J. Brasier, D.E. Feldman, and B.D. Philpot Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity Neuroscientist 14 2008 609 625
22. 2+-permeable AMPA receptors: synaptic plasticity and beyond Curr. Opin. Neurobiol. 16 2006 288 297
23. J. Dickerson, and F.R. Sharp Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801 Neuropsychopharmacol 31 2006 1420 1430
24. T. Enomoto, Y. Noda, A. Mouri, E.J. Shin, D. Wang, R. Murai, K. Hotta, H. Furukawa, A. Nitta, H.C. Kim, and T. Nabeshima Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-d-aspartate- extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine Mol. Pharmacol. 68 2005 1765 1774 (Pubitemid 41654359)
25. N.B. Farber, D.F. Wozniak, M.T. Price, J. Labruyere, J. Huss, H. St Peter, and J.W. Olney Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry 38 1995 788 796 (Pubitemid 3020005)
26. N.B. Farber The NMDA receptor hypofunction model of psychosis Ann. NY Acad. Sci. 1003 2003 119 130 (Pubitemid 38083050)
27. W.J. Gao, and P.S. Goldman-Rakic Selective modulation of excitatory and inhibitory microcircuits by dopamine Proc. Natl. Acad. Sci. U S A 100 2003 2836 2841 (Pubitemid 36297585)
28. X.M. Gao, and C.A. Tamminga MK-801 induces late regional increases in NMDA and kainate receptor binding in rat brain J. Neural Transm. Gen. Sect. 101 1995 105 113
29. W.J. Gao, L.S. Krimer, and P.S. Goldman-Rakic Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits Proc. Natl. Acad. Sci. U S A 98 2001 295 300 (Pubitemid 32095903)
30. W.J. Gao, Y. Wang, and P.S. Goldman-Rakic Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex J. Neurosci. 23 2003 1622 1630 (Pubitemid 36314717)
31. G. Gilmour, S. Dix, L. Fellini, F. Gastambide, N. Plath, T. Steckler, J. Talpos, and M. Tricklebank NMDA receptors, cognition and schizophrenia - testing the validity of the NMDA receptor hypofunction hypothesis Neuropharmacology 2011
32. John A. Gray, Y. Shi, H. Usui, Matthew J. During, K. Sakimura, and Roger A. Nicoll Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo Neuron 71 2011 1085 1101
33. H. Grunze, D. Rainnie, M. Hasselmo, E. Barkai, E. Hearn, R. McCarley, and R. Greene NMDA-dependent modulation of CA1 local circuit inhibition J. Neurosci. 16 1996 2034 2043 (Pubitemid 26144016)
34. H. Gunduz-Bruce The acute effects of NMDA antagonism: from the rodent to the human brain Brain Res. Rev. 60 2009 279 286
35. T. Hajszan, C. Leranth, and R.H. Roth Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex Biol. Psychiatry 60 2006 639 644 (Pubitemid 44402369)
36. L.W. Harris, T. Sharp, J. Gartlon, D.N. Jones, and P.J. Harrison Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism Eur. J. Neurosci. 18 2003 1706 1710 (Pubitemid 37215123)
37. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108 (Pubitemid 24117025)
38. H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons J. Neurosci. 27 2007 11496 11500 (Pubitemid 350006886)
39. J.T. Isaac, M. Ashby, and C.J. McBain The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity Neuron 54 2007 859 871 (Pubitemid 46907505)
40. M. Isokawa Membrane time constant as a tool to assess cell degeneration Brain Res. Brain Res. Protoc. 1 1997 114 116 (Pubitemid 28281331)
41. M.E. Jackson, H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex Proc. Natl. Acad. Sci. U S A 101 2004 8467 8472 (Pubitemid 38736598)
42. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
43. D.C. Javitt Glutamate as a therapeutic target in psychiatric disorders Mol. Psychiatry 9 2004 984 997 (Pubitemid 39524288)
44. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacol 20 1999 201 225 (Pubitemid 29067401)
45. J.D. Jentsch, J.D. Elsworth, D.E. Redmond Jr., and R.H. Roth Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966 J. Neurosci. 17 1997 1769 1775 (Pubitemid 27089821)
46. J.D. Jentsch, D.E. Redmond Jr., J.D. Elsworth, J.R. Taylor, K.D. Youngren, and R.H. Roth Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine Science 277 1997 953 955 (Pubitemid 27366680)
47. J.D. Jentsch, A. Tran, D. Le, K.D. Youngren, and R.H. Roth Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat Neuropsychopharmacology 17 1997 92 99
48. P. Jonas, and N. Burnashev Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels Neuron 15 1995 987 990
49. P. Jourdain, L.H. Bergersen, K. Bhaukaurally, P. Bezzi, M. Santello, M. Domercq, C. Matute, F. Tonello, V. Gundersen, and A. Volterra Glutamate exocytosis from astrocytes controls synaptic strength Nat. Neurosci. 10 2007 331 339
50. K. Kato, Y. Sekino, H. Takahashi, H. Yasuda, and T. Shirao Increase in AMPA receptor-mediated miniature EPSC amplitude after chronic NMDA receptor blockade in cultured hippocampal neurons Neurosci. Lett. 418 2007 4 8 (Pubitemid 46602688)
51. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers Jr., and D.S. Charney Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch. Gen. Psychiatry 51 1994 199 214 (Pubitemid 24081509)
52. S.S. Kumar, A. Bacci, V. Kharazia, and J.R. Huguenard A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons J. Neurosci. 22 2002 3005 3015 (Pubitemid 35379189)
53. A.C. Lahti, B. Koffel, D. LaPorte, and C.A. Tamminga Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1995 9 19
54. D.A. Lewis, T. Hashimoto, and D.W. Volk Cortical inhibitory neurons and schizophrenia Nat. Rev. Neurosci. 6 2005 312 324 (Pubitemid 40469985)
55. Q. Li, S. Clark, D.V. Lewis, and W.A. Wilson NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity J. Neurosci. 22 2002 3070 3080 (Pubitemid 35379196)
56. J.T. Li, Y.A. Su, C.M. Guo, Y. Feng, Y. Yang, R.H. Huang, and T.M. Si Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats Eur. J. Pharmacol. 652 2011 65 72
57. J.S. Lindahl, and J. Keifer Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine Neuropsychopharmacology 29 2004 2065 2073 (Pubitemid 39486558)
58. C.W. Lindsley, W.D. Shipe, S.E. Wolkenberg, C.R. Theberge, D.L. Williams Jr., C. Sur, and G.G. Kinney Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia Curr. Top. Med. Chem. 6 2006 771 785
59. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci. 31 2008 234 242
60. S.Q. Liu, and S.G. Cull-Candy Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype Nature 405 2000 454 458 (Pubitemid 30367421)
61. 2+-permeable AMPA receptors in synaptic plasticity and neuronal death Trends Neurosci. 30 2007 126 134 (Pubitemid 46283597)
62. B. Liu, M. Liao, J.G. Mielke, K. Ning, Y. Chen, L. Li, Y.H. El-Hayek, E. Gomez, R.S. Zukin, M.G. Fehlings, and Q. Wan Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites J. Neurosci. 26 2006 5309 5319 (Pubitemid 44318383)
63. A. Luthi, L. Schwyzer, J.M. Mateos, B.H. Gahwiler, and R.A. McKinney NMDA receptor activation limits the number of synaptic connections during hippocampal development Nat. Neurosci. 4 2001 1102 1107 (Pubitemid 34116555)
64. S. Mandillo, A. Rinaldi, A. Oliverio, and A. Mele Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits Behav. Pharmacol. 14 2003 533 544 (Pubitemid 38293514)
65. M.J. Marino, and P.J. Conn Direct and indirect modulation of the N-methyl d-aspartate receptor Curr. Drug Targets CNS Neurol. Disord. 1 2002 1 16
66. S.S. Mathew, and J.J. Hablitz Presynaptic NMDA receptors mediate IPSC potentiation at GABAergic synapses in developing rat neocortex PLoS One 6 2011 e17311
67. D.B. Matthews, J.E. Kralic, L.L. Devaud, J.M. Fritschy, and A.L. Marrow Chronic blockade of N-methyl-d-aspartate receptors alters gamma-aminobutyric acid type A receptor peptide expression and function in the rat J. Neurochem. 74 2000 1522 1528 (Pubitemid 30163973)
68. J.H. Meador-Woodruff, and D.J. Healy Glutamate receptor expression in schizophrenic brain Brain Res. Brain Res. Rev. 31 2000 288 294 (Pubitemid 30136183)
69. M.J. Millan N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives Psychopharmacology (Berl) 179 2005 30 53 (Pubitemid 40576691)
70. B. Moghaddam, and M.E. Jackson Glutamatergic animal models of schizophrenia Ann. NY Acad. Sci. 1003 2003 131 137 (Pubitemid 38083051)
71. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J. Neurosci. 17 1997 2921 2927 (Pubitemid 27155025)
72. B. Moghaddam Bringing order to the glutamate chaos in schizophrenia Neuron 40 2003 881 884 (Pubitemid 37522046)
73. R. Murai, Y. Noda, K. Matsui, H. Kamei, A. Mouri, K. Matsuba, A. Nitta, H. Furukawa, and T. Nabeshima Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling Behav. Brain Res. 180 2007 152 160 (Pubitemid 46719421)
74. K. Nakazawa, V. Zsiros, Z. Jiang, K. Nakao, S. Kolata, S. Zhang, and J.E. Belforte GABAergic interneuron origin of schizophrenia pathophysiology Neuropharmacology Jan 25 2011 [Epub ahead of print]
75. R. Nakki, F.R. Sharp, S.M. Sagar, and J. Honkaniemi Effects of phencyclidine on immediate early gene expression in the brain J. Neurosci. Res. 45 1996 13 27 (Pubitemid 26242073)
76. J.W. Olney, and N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch. Gen. Psychiatry 52 1995 998 1007
77. J.W. Olney, J. Labruyere, G. Wang, D.F. Wozniak, M.T. Price, and M.A. Sesma NMDA antagonist neurotoxicity: mechanism and prevention Science 254 1991 1515 1518 (Pubitemid 21917493)
78. L. Paulson, P. Martin, A. Persson, C.L. Nilsson, E. Ljung, A. Westman-Brinkmalm, P.S. Eriksson, K. Blennow, and P. Davidsson Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats J. Neurosci. Res. 71 2003 526 533 (Pubitemid 36158336)
79. D. Pinault N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex Biol. Psychiatry 63 2008 730 735 (Pubitemid 351400766)
80. K. Plant, K.A. Pelkey, Z.A. Bortolotto, D. Morita, A. Terashima, C.J. McBain, G.L. Collingridge, and J.T.R. Isaac Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation Nat. Neurosci. 9 2006 602 604 (Pubitemid 44012255)
81. J.A. Pratt, C. Winchester, A. Egerton, S.M. Cochran, and B.J. Morris Modelling prefrontal cortex deficits in schizophrenia: implications for treatment Br. J. Pharmacol. 153 Suppl. 1 2008 S465 S470
82. B.A. Rasmussen, J. O'Neil, K.F. Manaye, D.C. Perry, and Y. Tizabi Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats Psychopharmacology (Berl) 190 2007 43 49 (Pubitemid 44885342)
83. G.P. Reynolds, Z. Abdul-Monim, J.C. Neill, and Z.J. Zhang Calcium binding protein markers of GABA deficits in schizophrenia-postmortem studies and animal models Neurotox. Res. 6 2004 57 61
84. A. Rodriguez-Moreno, and O. Paulsen Spike timing-dependent long-term depression requires presynaptic NMDA receptors Nat. Neurosci. 11 2008 744 745 (Pubitemid 351896669)
85. D.C. Rotaru, H. Yoshino, D.A. Lewis, G.B. Ermentrout, and G. Gonzalez-Burgos Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia J. Neurosci. 31 2011 142 156
86. D. Rujescu, A. Bender, M. Keck, A.M. Hartmann, F. Ohl, H. Raeder, I. Giegling, J. Genius, R.W. McCarley, H.J. Moller, and H. Grunze A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities Biol. Psychiatry 59 2006 721 729
87. U. Schroeder, H. Schroeder, H. Schwegler, and B.A. Sabel Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory Br. J. Pharmacol. 130 2000 33 40 (Pubitemid 30248423)
88. S.M. Simpson, J.L. Menard, J.N. Reynolds, and R.J. Beninger Post-weaning social isolation increases activity in a novel environment but decreases defensive burying and subchronic MK-801 enhances the activity but not the burying effect in rats Pharmacol. Biochem. Behav. 95 2010 72 79
89. P.J. Sjostrom, G.G. Turrigiano, and S.B. Nelson Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors Neuron 39 2003 641 654 (Pubitemid 36993581)
90. L.P. Spear The adolescent brain and age-related behavioral manifestations Neurosci. Biobehav Rev. 24 2000 417 463 (Pubitemid 30243061)
91. J.F. Storm Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells J. Physiol. 385 1987 733 759 (Pubitemid 17048959)
92. M.A. Sutton, N.R. Wall, G.N. Aakalu, and E.M. Schuman Regulation of dendritic protein synthesis by miniature synaptic events Science 304 2004 1979 1983 (Pubitemid 38822192)
93. M.A. Sutton, H.T. Ito, P. Cressy, C. Kempf, J.C. Woo, and E.M. Schuman Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis Cell 125 2006 785 799
94. H. Tanaka, S.Y. Grooms, M.V. Bennett, and R.S. Zukin The AMPAR subunit GluR2: still front and center-stage Brain Res. 886 2000 190 207
95. K. Toth, and C.J. McBain Target-specific expression of pre- and postsynaptic mechanisms J. Physiol. 525 Pt. 1 2000 41 51 (Pubitemid 30311932)
96. K.Y. Tseng, and P. O'Donnell Dopamine modulation of prefrontal cortical interneurons changes during adolescence Cereb. Cortex 17 2007 1235 1240 (Pubitemid 46598865)
97. G.G. Turrigiano, and S.B. Nelson Homeostatic plasticity in the developing nervous system Nat. Rev. Neurosci. 5 2004 97 107 (Pubitemid 38160285)
98. P.J. Uhlhaas, and W. Singer Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology Neuron 52 2006 155 168 (Pubitemid 44466360)
99. P.J. Uhlhaas, and W. Singer Abnormal neural oscillations and synchrony in schizophrenia Nat. Rev. Neurosci. 11 2010 100 113
100. L.T. van Elst, G. Valerius, M. Buchert, T. Thiel, N. Rusch, E. Bubl, J. Hennig, D. Ebert, and H.M. Olbrich Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study Biol. Psychiatry 58 2005 724 730 (Pubitemid 41547240)
101. A. Vezzani, R. Serafini, M.A. Stasi, S. Caccia, I. Conti, R.V. Tridico, and R. Samanin Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats J. Pharmacol. Exp. Ther. 249 1989 278 283 (Pubitemid 19115820)
102. H.X. Wang, and W.J. Gao Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex Neuropsychopharmacology 34 2009 2028 2040
103. H.X. Wang, and W.J. Gao Development of calcium-permeable AMPA receptors and their correlation with NMDA receptors in fast-spiking interneurons of rat prefrontal cortex J. Physiol. 588 2010 2823 2838
104. C. Wang, V.M. Showalter, G.R. Hillman, and K.M. Johnson Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain J. Neurosci. Res. 55 1999 762 769 (Pubitemid 29173489)
105. C.Z. Wang, S.F. Yang, Y. Xia, and K.M. Johnson Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons Neuropsychopharmacology 2008 2442 2455
106. H.X. Wang, G.G.r. Stradtman, X.J. Wang, and W.J. Gao A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex Proc. Natl. Acad. Sci. U S A 105 2008 16791 16796
107. G. Woodhall, D.I. Evans, M.O. Cunningham, and R.S. Jones NR2B-containing NMDA autoreceptors at synapses on entorhinal cortical neurons J. Neurophysiol. 86 2001 1644 1651 (Pubitemid 32953215)
108. D. Xi, B. Keeler, W. Zhang, J.D. Houle, and W.J. Gao NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser micro dissection technique J. Neurosci. Methods 176 2009 172 181
109. D. Xi, W. Zhang, H.X. Wang, G.G. Stradtman, and W.J. Gao Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex Int. J. Neuropsychopharmacol. 12 2009 1395 1408
110. D. Xi, Y.-C. Li, M.A. Snyder, R.Y. Gao, A.E. Adelman, W. Zhang, J.S. Shumsky, and W.-J. Gao Group II metabotropic glutamate receptor agonist ameliorates MK-801-induced dysfunction of NMDA receptors via Akt/GSK-3beta pathway Neuropsychopharmacology 36 2011 1260 1274
111. J. Yang, G.L. Woodhall, and R.S. Jones Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats J. Neurosci. 26 2006 406 410 (Pubitemid 43237103)
112. Y. Zhang, M. Behrens, and J.E. Lisman Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex J. Neurophysiol. 100 2008 959 965